
High-Quality STROMUSC 1-Testosterone Cypionate(DHB)10mg For Bodybuilding CAS:65-06-5
In the ever-evolving landscape of performance enhancement, certain compounds develop a reputation that transcends their underground origins. Dihydroboldenone Cypionate—better known in bodybuilding circles as DHB or 1-Testosterone Cypionate—is one such substance. Described by some as a "secret weapon" and by others as a double-edged sword, DHB occupies a unique pharmacological niche that has captured the attention of experienced lifters seeking dry, quality muscle gains without the estrogenic baggage of traditional testosterone derivatives.
What Is DHB (1-Testosterone Cypionate)?
DHB-dihydroboldenone-is the 5α-reduced derivative of boldenone, the parent compound of the veterinary steroid Equipoise. Structurally, it is a DHT molecule with a 1(2)-double bond replacing testosterone's 4(5)-double bond. This seemingly minor structural rearrangement has profound pharmacological consequences.
First synthesized in the 1960s, DHB has never received FDA approval for any medical indication. All DHB products currently available are manufactured by underground laboratories, a fact that carries significant implications for quality control and dosing consistency.
The compound is often referred to as 1-Testosterone, a name that creates some confusion. It is not testosterone itself but rather a structural analog that binds to the androgen receptor with potency comparable to testosterone while possessing a fundamentally different metabolic profile.
The Cypionate Ester
The cypionate ester attached to the DHB molecule serves a specific purpose: it slows the release of the active compound into systemic circulation. This esterification extends the half-life to approximately 7-9 days, allowing for less frequent administration compared to shorter esters like acetate. For oral tablet formulations, this esterification is less directly relevant to release kinetics, as oral administration bypasses the depot effect that characterizes injectable preparations.


Key Features and Pharmacology
Androgenic-Anabolic Profile
DHB possesses an anabolic rating of approximately 200 (with testosterone set at 100) and an androgenic rating of approximately 100. This means it delivers twice the muscle-building signal of testosterone milligram-for-milligram, with comparable androgenic activity. This ratio makes it an attractive option for users seeking substantial lean tissue accretion without excessive androgenic side effects.
Non-Aromatizing Nature
Perhaps DHB's most celebrated pharmacological feature is its inability to aromatize to estrogen. As a 5α-reduced steroid, it is not a substrate for the aromatase enzyme. This eliminates several estrogen-related concerns that plague users of aromatizable compounds:
●No water retention or bloating
●No gynecomastia risk from the compound itself
●No need for aromatase inhibitors to manage DHB-derived estrogen
Non-Reducible
DHB is already 5α-reduced, meaning it cannot be further converted to more androgenic metabolites by 5α-reductase. This has practical implications: finasteride and other 5α-reductase inhibitors offer no scalp protection when running DHB, as the compound itself is already in its reduced form.
Mechanism of Action
DHB exerts its effects through direct binding to the androgen receptor in muscle cells. This binding stimulates protein synthesis, enhances nitrogen retention, and increases IGF-1 expression in skeletal muscle. The compound also improves insulin sensitivity, potentially enhancing nutrient uptake into muscle cells and improving recovery between training sessions.
Applications in Bodybuilding
Lean Bulking
DHB shines brightest in lean bulking scenarios. Users report dry, hard, vascular gains characterized by quality tissue accretion without the "puffy" look associated with high-estrogen compounds. The aesthetic signature produced by DHB has drawn comparisons to Primobolan, with some users describing it as the "poor man's primo".
However, it is crucial to temper expectations. DHB does not produce the rapid, dramatic transformations associated with compounds like Trenbolone. Gains are described as "slow-quality" rather than explosive. This makes DHB better suited for patient, experienced users who value quality over speed.
Cutting and Recomposition
The non-aromatizing, non-bloating nature of DHB makes it particularly effective during cutting phases. Users can maintain or even build lean tissue while in a caloric deficit, preserving muscle mass during periods of reduced energy intake. The hardening effect-a denser, more defined muscular appearance-is often cited as a primary benefit during contest preparation or aesthetic-focused cycles.
Stacking
DHB is virtually never run as a standalone compound. Its profound suppression of endogenous testosterone production, combined with its inability to provide estrogenic support, necessitates the inclusion of a testosterone base.
Typical DHB-to-testosterone ratios range from 1:4 to 1:2-for example, 200-400mg of DHB paired with 500-800mg of testosterone per week. The testosterone base provides the estradiol necessary for libido, joint health, cardiovascular function, and neuroprotection-all of which DHB cannot supply.
Benefits
1. Dry, Quality Muscle Gains
DHB delivers lean tissue without the water retention that accompanies aromatizable compounds. The resulting physique is harder, more defined, and more aesthetic. For athletes competing in weight-class sports or bodybuilders approaching contest prep, this quality is invaluable.
2. No Estrogenic Side Effects
The absence of aromatization eliminates gynecomastia risk, water retention, and bloating from the compound itself. This simplifies cycle management considerably, as users need not monitor estradiol levels specifically for DHB-derived estrogen.
3. Potent Anabolic Signal
With an anabolic rating double that of testosterone, DHB delivers substantial muscle-building stimulus at relatively modest doses. Users running 400-500mg per week on a test base consistently report significant gains in both size and strength.
4. Improved Nitrogen Retention
DHB enhances nitrogen retention, a critical factor in muscle protein synthesis. Better nitrogen balance means the body remains in an anabolic state conducive to tissue growth and maintenance.
5. Favorable Side Effect Profile (Relative)
Compared to Trenbolone, DHB is significantly milder in terms of central nervous system effects. It lacks the progestogenic activity, insomnia, night sweats, and psychological sides that make Trenbolone challenging for many users. Users often describe DHB as "Tren without the mental sides".
Dosage Considerations
Oral DHB: A Critical Distinction
The 10mg tablet formulation of DHB represents a departure from the injectable preparations more commonly discussed in bodybuilding circles. Oral administration introduces several considerations that deserve careful attention.
First, oral bioavailability of non-17α-alkylated steroids is generally poor. Unlike methylated oral compounds designed specifically for oral delivery, standard DHB (1-Testosterone Cypionate) was never formulated for oral administration. The cypionate ester is intended for intramuscular injection, where it forms a depot that slowly releases the active compound.
Second, there is historical precedent for oral 1-testosterone products. Methyl 1-Testosterone-a 17α-methylated derivative designed for oral bioavailability-was sold in 5mg and 10mg tablets. This compound is a different entity from standard 1-Testosterone Cypionate and carries significantly different pharmacokinetic and toxicity profiles. Methyl 1-Test is notably hepatotoxic due to the 17α-methylation that enables oral delivery.
Users encountering "DHB 10mg tablets" should carefully verify which compound they are actually dealing with-standard 1-Testosterone Cypionate or the methylated oral variant. The distinction is not merely academic; it has profound implications for dosing, liver toxicity, and expected outcomes.
Injectable DHB Dosing (Reference)
For context, injectable DHB (1-Testosterone Cypionate) is typically dosed as follows:
●Beginner: 200-300mg per week
●Intermediate: 300-400mg per week
●Advanced: 400-500mg per week
Dosing frequency for the cypionate ester is typically 2-3 injections per week due to the ~8-day half-life.
These injectable dosing references serve as a baseline for understanding the compound's potency. Oral formulations, depending on their specific chemistry, would require different dosing considerations that are not well-established in the literature.
Cycle Structure
Typical Cycle Length
DHB cycles typically run 10-16 weeks. The longer duration aligns with the cypionate ester's extended half-life, allowing for steady-state blood concentrations to be achieved and maintained.
Sample Cycle Protocol
A standard DHB cycle might look like:
●Weeks 1-12: DHB (injectable) 300-400mg per week, split into 2-3 administrations
●Weeks 1-12: Testosterone base 500-800mg per week (or a TRT dose of 150-200mg for those preferring minimal estrogenic load)
●Aromatase inhibitor: Dosed based on blood work and symptoms; not required for DHB itself but potentially needed for the testosterone base
Cycle Monitoring
Experienced users monitor several biomarkers during a DHB cycle:
●Lipid profile: DHB can negatively impact cholesterol
●Blood pressure: Androgen use commonly elevates BP
●Hematocrit: Increased red blood cell production is a concern
●CRP (C-reactive protein): DHB is known to elevate CRP in some users
Half-Life and Pharmacokinetics
1-Testosterone Cypionate Half-Life
The cypionate ester extends the half-life of DHB to approximately 7-9 days. This means that after a single injection, it takes roughly 8 days for the drug concentration in the blood to decrease by half.
Peak and Active Duration
Peak concentrations are typically reached approximately 48 hours post-injection. The active duration extends to approximately 192 hours (8 days).
Implications for Tablets
The half-life data cited above applies to injectable formulations. Oral tablet formulations would have fundamentally different pharmacokinetics due to first-pass metabolism, different absorption characteristics, and potentially different esterification or methylation.
Steady-State Considerations
With a half-life of ~8 days, it takes approximately 40 days (5 half-lives) to reach steady-state blood concentrations when dosing at regular intervals. This long ramp-up period is one reason why DHB cycles are typically 10-16 weeks in duration-shorter cycles may not allow sufficient time at steady-state concentrations to realize the compound's full benefits.
Post-Cycle Therapy (PCT)
Why PCT Is Essential
DHB is profoundly suppressive of endogenous testosterone production. It shuts down the hypothalamic-pituitary-gonadal axis through negative feedback, and because it does not aromatize, it provides none of the estrogenic signaling that might partially mitigate suppression. Recovery without PCT is unlikely and potentially prolonged.
PCT Protocol
A full SERM-based PCT is required following a DHB cycle:
●Nolvadex (Tamoxifen): 40mg daily for 2 weeks, followed by 20mg daily for 2 weeks (40/40/20/20)
●Alternative (Clomid): 50mg daily for 2 weeks, followed by 25mg daily for 2 weeks (50/50/25/25)
Timing
PCT should begin approximately 2.5-3 weeks after the last administration of 1-Testosterone Cypionate. This waiting period allows the exogenous compound to clear sufficiently so that the SERM can effectively stimulate endogenous testosterone production.
Additional PCT Considerations
Some users incorporate HCG (human chorionic gonadotropin) during the latter portion of the cycle or in the transition period before PCT to stimulate Leydig cell function and facilitate recovery. However, HCG use requires careful timing and dosing to avoid further suppression.
Risks and Side Effects
Post-Injection Pain (PIP)
For injectable DHB, PIP is the defining side effect. The compound has a high melting point and crystalline nature, causing it to precipitate out of solution in muscle tissue and trigger a localized inflammatory response. Pain typically begins 12-48 hours post-injection and can last 3-7 days.
This side effect is less relevant to oral tablet formulations but speaks to the compound's overall tissue reactivity.
Liver Toxicity
DHB has been reported to have mild hepatotoxic potential, which is unusual for a non-17α-alkylated injectable steroid. Elevated liver enzymes (ALT/AST) have been reported even with injectable administration. This toxicity may relate to the compound's metabolic pathway or the carrier solvents used in underground lab formulations.
For oral formulations-particularly methylated variants-liver toxicity is a significantly greater concern.
Comparison to Other Compounds
DHB vs. Primobolan
Both compounds deliver dry, quality gains without estrogenic side effects. DHB is generally considered more potent milligram-for-milligram than Primobolan and is significantly cheaper. However, Primobolan has a longer track record of human use and a more established safety profile.
DHB vs. Trenbolone
DHB is often described as "Tren without the mental sides". It lacks Trenbolone's progestogenic activity, severe CNS effects, and extreme androgenic punch. However, DHB also lacks Trenbolone's dramatic, rapid transformation potential.
DHB vs. Testosterone
Testosterone provides estrogenic support that DHB cannot. DHB is more anabolic milligram-for-milligram but requires a testosterone base for physiological function. The two are complementary rather than interchangeable.
Clinical Data
| Brand | STROMUSC |
|
Trade names |
1-Testo; 1-T; δ1-Dihydrotestosterone; δ1-DHT; Dihydroboldenone;Dihydroboldenone Cypionate/DHB |
|
CAS |
65-06-5 |
|
Molar mass |
288.431 |
|
Formula |
C19H28O2 |
|
Purity |
Above 98% |
|
Apprarance |
10mg*100 |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785

Conclusion
Top-quality DHB (1-Testosterone Cypionate) in 10mg tablet form represents a complex proposition in the bodybuilding landscape. The compound itself-when properly formulated and administered-offers a compelling profile: potent anabolic activity, no estrogenic side effects, dry quality gains, and a side effect profile that many experienced users find manageable.
However, significant caveats apply. The tablet formulation raises questions about bioavailability, actual compound identity (standard vs. methylated), and hepatic safety. The compound's underground manufacturing status introduces quality control concerns. The necessity of a testosterone base complicates cycle design. And the profound suppression of natural testosterone production demands a serious commitment to proper PCT.
For the informed, experienced user who understands these realities, DHB can be a valuable tool in the pursuit of quality muscle development. For the novice or the uninformed, it represents a risk profile that likely outweighs any potential benefit. As with all performance-enhancing compounds, the decision to use DHB should be made with full awareness of the pharmacological realities, legal implications, and health risks involved.
Hot Tags: high-quality stromusc 1-testosterone cypionate(dhb)10mg for bodybuilding cas:65-06-5, China high-quality stromusc 1-testosterone cypionate(dhb)10mg for bodybuilding cas:65-06-5 manufacturers, suppliers, factory
